Chilton Capital Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$66K Buy
299
+153
+105% +$42.3K ﹤0.01% 319
2026
Q1
$43.1K Sell
146
-3
-2% -$891 ﹤0.01% 349
2025
Q4
$40.7K Sell
149
-105
-41% -$28.5K ﹤0.01% 352
2025
Q3
$68.6K Sell
254
-127
-33% -$34.6K ﹤0.01% 325
2025
Q2
$105K Buy
+381
New +$104K ﹤0.01% 275
2025
Q1
Sell
-8
Closed -$1.86K 546
2024
Q4
$1.86K Buy
8
+3
+60% +$690 ﹤0.01% 525
2024
Q3
$1.1K Hold
5
﹤0.01% 618
2024
Q2
$983 Sell
5
-83
-94% -$17.1K ﹤0.01% 579
2024
Q1
$18.9K Buy
+88
New +$18.5K ﹤0.01% 428
2014
Q1
Sell
-20
Closed -$1.57K 189
2013
Q4
$1.57K Hold
20
﹤0.01% 368
2013
Q3
$1.48K Hold
20
﹤0.01% 375
2013
Q2
$2K Buy
+20
New +$1.31K ﹤0.01% 372

Other funds holding CME

Chilton Capital Management's CME Position: Q2 2026 in Review

Chilton Capital Management increased its CME Group (CME) stake by 105% in Q2 2026, buying an estimated $42.3K and bringing the position to 299 shares worth $66K. The position accounts for ﹤0.01% of the portfolio, ranked #319.

Chilton Capital Management first reported a position in CME in Q2 2013 and has held it in 12 quarters since. The position peaked at $105K in Q2 2025. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Chilton Capital Management held 299 shares of CME Group worth $66K as of Q2 2026.
  • Chilton Capital Management bought 153 CME Group shares in Q2 2026, an estimated $42.3K.
  • CME Group made up ﹤0.01% of Chilton Capital Management's portfolio in Q2 2026, its #319 holding.
  • Chilton Capital Management first reported a position in CME Group in Q2 2013 and has held it in 12 quarters since.
  • Chilton Capital Management's CME Group position peaked at $105K in Q2 2025.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Chilton Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.